Copyright Reports & Markets. All rights reserved.

Global Biologic Injectors Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Biologic Injectors Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Biologic Injectors Market Size Growth Rate by Product
      • 1.4.2 Disposable Biologic Injectors
      • 1.4.3 Reusable Biologic Injectors
    • 1.5 Market by End User
      • 1.5.1 Global Biologic Injectors Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Ambulatory Surgical Centers
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Biologic Injectors Market Size
      • 2.1.1 Global Biologic Injectors Revenue 2014-2025
      • 2.1.2 Global Biologic Injectors Sales 2014-2025
    • 2.2 Biologic Injectors Growth Rate by Regions
      • 2.2.1 Global Biologic Injectors Sales by Regions
      • 2.2.2 Global Biologic Injectors Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Biologic Injectors Sales by Manufacturers
      • 3.1.1 Biologic Injectors Sales by Manufacturers
      • 3.1.2 Biologic Injectors Sales Market Share by Manufacturers
      • 3.1.3 Global Biologic Injectors Market Concentration Ratio (CR5 and HHI)
    • 3.2 Biologic Injectors Revenue by Manufacturers
      • 3.2.1 Biologic Injectors Revenue by Manufacturers (2014-2019)
      • 3.2.2 Biologic Injectors Revenue Share by Manufacturers (2014-2019)
    • 3.3 Biologic Injectors Price by Manufacturers
    • 3.4 Biologic Injectors Manufacturing Base Distribution, Product Types
      • 3.4.1 Biologic Injectors Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Biologic Injectors Product Type
      • 3.4.3 Date of International Manufacturers Enter into Biologic Injectors Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Biologic Injectors Sales by Product
    • 4.2 Global Biologic Injectors Revenue by Product
    • 4.3 Biologic Injectors Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Biologic Injectors Breakdown Data by End User

    6 North America

    • 6.1 North America Biologic Injectors by Countries
      • 6.1.1 North America Biologic Injectors Sales by Countries
      • 6.1.2 North America Biologic Injectors Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Biologic Injectors by Product
    • 6.3 North America Biologic Injectors by End User

    7 Europe

    • 7.1 Europe Biologic Injectors by Countries
      • 7.1.1 Europe Biologic Injectors Sales by Countries
      • 7.1.2 Europe Biologic Injectors Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Biologic Injectors by Product
    • 7.3 Europe Biologic Injectors by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Biologic Injectors by Countries
      • 8.1.1 Asia Pacific Biologic Injectors Sales by Countries
      • 8.1.2 Asia Pacific Biologic Injectors Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Biologic Injectors by Product
    • 8.3 Asia Pacific Biologic Injectors by End User

    9 Central & South America

    • 9.1 Central & South America Biologic Injectors by Countries
      • 9.1.1 Central & South America Biologic Injectors Sales by Countries
      • 9.1.2 Central & South America Biologic Injectors Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Biologic Injectors by Product
    • 9.3 Central & South America Biologic Injectors by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Biologic Injectors by Countries
      • 10.1.1 Middle East and Africa Biologic Injectors Sales by Countries
      • 10.1.2 Middle East and Africa Biologic Injectors Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Biologic Injectors by Product
    • 10.3 Middle East and Africa Biologic Injectors by End User

    11 Company Profiles

    • 11.1 BD
      • 11.1.1 BD Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 BD Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 BD Biologic Injectors Products Offered
      • 11.1.5 BD Recent Development
    • 11.2 Johnson & Johnson
      • 11.2.1 Johnson & Johnson Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Johnson & Johnson Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Johnson & Johnson Biologic Injectors Products Offered
      • 11.2.5 Johnson & Johnson Recent Development
    • 11.3 Roche
      • 11.3.1 Roche Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Roche Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Roche Biologic Injectors Products Offered
      • 11.3.5 Roche Recent Development
    • 11.4 Schott
      • 11.4.1 Schott Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Schott Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Schott Biologic Injectors Products Offered
      • 11.4.5 Schott Recent Development
    • 11.5 Bayer
      • 11.5.1 Bayer Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bayer Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bayer Biologic Injectors Products Offered
      • 11.5.5 Bayer Recent Development
    • 11.6 Nipro
      • 11.6.1 Nipro Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Nipro Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Nipro Biologic Injectors Products Offered
      • 11.6.5 Nipro Recent Development
    • 11.7 Ompi
      • 11.7.1 Ompi Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Ompi Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Ompi Biologic Injectors Products Offered
      • 11.7.5 Ompi Recent Development
    • 11.8 Novartis
      • 11.8.1 Novartis Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Novartis Biologic Injectors Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Novartis Biologic Injectors Products Offered
      • 11.8.5 Novartis Recent Development

    12 Future Forecast

    • 12.1 Biologic Injectors Market Forecast by Regions
      • 12.1.1 Global Biologic Injectors Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Biologic Injectors Revenue Forecast by Regions 2019-2025
    • 12.2 Biologic Injectors Market Forecast by Product
      • 12.2.1 Global Biologic Injectors Sales Forecast by Product 2019-2025
      • 12.2.2 Global Biologic Injectors Revenue Forecast by Product 2019-2025
    • 12.3 Biologic Injectors Market Forecast by End User
    • 12.4 North America Biologic Injectors Forecast
    • 12.5 Europe Biologic Injectors Forecast
    • 12.6 Asia Pacific Biologic Injectors Forecast
    • 12.7 Central & South America Biologic Injectors Forecast
    • 12.8 Middle East and Africa Biologic Injectors Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Biologic Injectors Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.
      Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.
      The increasing demand for drug delivery is expected to be the major factor driving the growth of the biologic injectors market over the forecast period. The introduction of disposable and reusable biologic injectors is expected to drive the growth of the biologic injectors market.
      North America is expected to be the dominant region in the global biologic injectors market, owing to advancements in healthcare technologies in the region. Europe is expected to hold the second large share in the global biologic injectors market throughout the forecast period.
      The global Biologic Injectors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biologic Injectors market based on company, product type, end user and key regions.

      This report studies the global market size of Biologic Injectors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biologic Injectors in these regions.
      This research report categorizes the global Biologic Injectors market by top players/brands, region, type and end user. This report also studies the global Biologic Injectors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      BD
      Johnson & Johnson
      Roche
      Schott
      Bayer
      Nipro
      Ompi
      Novartis

      Market size by Product
      Disposable Biologic Injectors
      Reusable Biologic Injectors
      Market size by End User
      Hospitals
      Clinics
      Ambulatory Surgical Centers
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Biologic Injectors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Biologic Injectors market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Biologic Injectors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Biologic Injectors submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Biologic Injectors are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biologic Injectors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now